Concord Medical Announces Result of 2024 Annual General Meeting

CCM 01.06.2025

Full Press ReleaseSEC FilingsOur CCM Tweets

About Gravity Analytica

Recent News

  • 01.06.2025 - Concord Medical Announces Result of 2024 Annual General Meeting
  • 12.27.2024 - Concord Medical Services Holdings Limited 2024 Annual Meeting of Shareholders
  • 12.09.2024 - Concord Healthcare Announces Approval Granted to the Application for the Proton Therapy Equipment Registration Certificate

Recent Filings

  • 01.06.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
  • 01.06.2025 - EX-99.1 EX-99.1
  • 07.11.2024 - F-6 POS Post-effective amendments for immediately effective filing

BEIJING,Jan. 6, 2025/PRNewswire/ --Concord Medical Services Holdings Limited("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention inChina, today announced that it held its 2024 annual general meeting of shareholders onDecember 27, 2024. At the meeting, the shareholders resolved by special resolution that amended and replaced the Fourth Memorandum and Articles ofAssociation of the Companythen in effect by the adoption of the Fifth Amended and Restated Memorandum and Articles of Association.

About Concord Medical

Concord Medical Services Holdings Limitedis a healthcare provider featuring a full cycle of premium oncology services including cancer diagnosis, treatment, education and prevention. The Company focuses on providing multidisciplinary cancer care in all aspects of oncology healthcare services in its cancer hospitals and equipping them with technologically advanced equipment such as the state-of-the-art proton therapy system. The Company is striving to improve the quality and accessibility of cancer care through its network of self-owned cancer hospitals and clinics as well as partnered hospitals acrossChina. For more information, please seehttp://ir.ccm.cn.

Safe Harbor Statement

This announcement contains forward-looking statements. These forward-looking statements can be identified by words or phrases such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar expressions. Forward-looking statements are inherently subject to uncertainties and contingencies beyond the Company's control and based upon premises with respect to future business decisions, which are subject to change. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. The Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

CisionView original content:https://www.prnewswire.com/news-releases/concord-medical-announces-result-of-2024-annual-general-meeting-302342884.html

SOURCEConcord Medical Services Holdings Limited

Concord Medical Services Holdings Limited, Investor Relations, +86 10 5903 6688, ir@ccm.cn

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com